ReaDySpeech for people with dysarthria after stroke

ISRCTN ISRCTN84996500
DOI https://doi.org/10.1186/ISRCTN84996500
Secondary identifying numbers 18964
Submission date
20/05/2015
Registration date
21/05/2015
Last edited
24/01/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Dysarthria, or slurred speech, is caused by muscle weakness and is common after a stroke. It happens when areas of the brain or nervous system that control the muscles used for speech are damaged. Dysarthria can lead to people feeling isolated, unconfident and uncomfortable in social situations. Speech therapy can offer support to people with dysarthria and help to reduce its symptoms, but this treatment is not always provided within the NHS. The aim of this study is to test a new technology called ReaDySpeech, a specially designed computer programme which aims to provide patients with greater access to personalised speech rehabilitation. ReaDySpeech technology will be trialled in this study with both clinicians and patients to see what they think of it. If clinicians and patients find the technology acceptable, a larger study will be designed from its results so that it can be tested with more people.

Who can participate?
Adults with dysarthria following a stroke.

What does the study involve?
All participants are given access to the ReaDySpeech computer programme. Users are asked to provide feedback on ReaDySpeech.

What are the possible benefits and risks of participating?
Not provided at time of registration.

Where is the study run from?
University of Manchester (UK)

When is the study starting and how long is it expected to run for?
September 2015 to November 2016

Who is funding the study?
National Institute for Health Research (UK)

Who is the main contact?
Mrs C Mitchell

Contact information

Mrs Claire Mitchell
Scientific

University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom

Study information

Study designRandomised interventional treatment study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Home
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleReaDySpeech for people with dysarthria after stroke: a feasibility study
Study objectivesThis study will test the feasibility of a new speech rehabilitation technology, ReaDySpeech, developed for patients with dysarthria. This study will assess its acceptability with clinicians and patients, and the results will be used in the design of a larger study.
Ethics approval(s)Ref: 15/NW/0371.
Health condition(s) or problem(s) studiedStroke rehabilitation for dysarthria
InterventionParticipants will be given access to ReaDySpeech, a computer based programme designed to deliver speech therapy exercises to patients.
Intervention typeOther
Primary outcome measureActivity measure.
Secondary outcome measuresNot available at time of registration.
Overall study start date01/09/2015
Completion date01/11/2016

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsUK Sample Size: 36
Key inclusion criteria1. Participants will be selected by the clinician, within the inclusion criteria of more than 1 week post stroke
2. No upper limit to time post stroke
3. Participants will present with dysarthria, willing and able to undertake communication therapy (in clinicians' opinion)
4. Sufficient ability in English to participate in therapy without a translator
5. Medically stable
6. Able to give informed consent to participate
Key exclusion criteria1. Dysarthria for reason other than stroke
2. Not fluent in the English language (this may make using ReaDySpeech difficult)
3. Coexisting communication, cognitive, hearing or visual problems, significant enough to make using ReaDySpeech difficult
4. Coexisting progressive neurological condition
Date of first enrolment01/09/2015
Date of final enrolment01/11/2016

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom

Sponsor information

University of Manchester
Hospital/treatment centre

Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
England
United Kingdom

ROR logo "ROR" https://ror.org/027m9bs27

Funders

Funder type

Government

National Institute for Health Research
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 20/07/2017 Yes No
Results article results 01/08/2018 24/01/2019 Yes No
HRA research summary 28/06/2023 No No

Editorial Notes

24/01/2019: Publication reference added
24/07/2017: Publication reference added.